In the recent case of Wyeth v. Levine, the drug company unsuccessfully appealed an award to a patient who had been harmed by Phenergan—even though the FDA had approved this injectable drug. Dr. Field reviews this precedent-setting case.
You are here
P&T® Journal contents for May 2009
Health Care & Law
Supreme Court Finds That FDA Approval Does Not Stand In the Way
But American Recovery and Reinvestment Act Gives Pharmacies Short Shrift
The advent of electronic prescribing was supposed to be a large part of the cure for improving patient outcomes and reducing prescription errors, but only a fraction of scripts are being sent electronically. Independent and hospital pharmacies continue to lag behind the technology wave because of the expense involved.
Clinical and Financial Implications
Although H.P. Acthar Gel has been beneficial in MS, spasms, and adrenal testing, its high cost has led to a larger role for alternatives like cosyntropin and steroids.
Summaries include clinical trials involving statins; eptifibatide; non-statins (Zetia); and a "polypill" containing antihypertensive agents, a statin, and aspirin (PolyCap).
Topics include Afinitor for renal cell carcinoma; Ixiaro vaccine to prevent Japanese encephalitis; and ATryn, an antithrombin product engineered from goats.